Mental Health & Behavioral Research, Phase III

Efficacy and Safety Study of Adjunctive Troriluzole in Obsessive Compulsive Disorder

Volunteers
Health Professionals

What is the purpose of this trial?

The study's purpose is to evaluate the efficacy and safety of troriluzole as adjunctive therapy compared to placebo in subjects with Obsessive Compulsive Disorder (OCD).

Trial with
Biohaven Pharmaceuticals Inc.
Ages
18 years - 65 years
Gender
Both

Find out more about who can participate in this trial

Contact Information

For more information about this study, including how to volunteer, contact OCD Clinic

Help Us Discover!

You can help our team find trials you might be eligible for by creating a volunteer profile in MyChart. To get started, create a volunteer profile, or contact helpusdiscover@yale.edu, or call 877.978.8343 for more information.

Create a volunteer profile

Principal Investigator

Christopher Pittenger, MD, PhD
Elizabeth Mears and House Jameson Professor of Psychiatry; Deputy Chair for Translational Research, Psychiatry; Director, Clinical Neuroscience Research Unit, Psychiatry; Director, Yale Program for Psychedelic Science, Psychiatry; Director, Yale Center for Brain and Mind Health, Yale School of Medicine; Director, Yale OCD Research Clinic, Psychiatry; Director, Neuroscience Research Training Program, Yale Department of Psychiatry

Sub-Investigators

Last Updated
09/15/2023
Study HIC
#2000029681